+76,920.8%
NVDA vs ABBV
+1,125.5%
+75,795.2%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ABBV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -3.0% | +1.0% | -1.1% |
| 7D | +3.8% | -4.3% | +8.1% | +5.2% |
| 30D | +0.8% | +1.1% | -0.3% | +0.3% |
| 3M | +8.2% | +12.3% | -4.1% | +3.6% |
| 6M | +27.1% | +9.8% | +17.3% | +22.2% |
| YTD | +21.2% | +11.5% | +9.7% | +15.7% |
| 1Y | +34.3% | +22.3% | +12.0% | +23.6% |
| 3Y | +396.3% | +85.2% | +311.1% | +281.5% |
| 5Y | +913.8% | +170.8% | +743.0% | +552.7% |
| 10Y | +14,572.5% | +485.4% | +14,087.1% | +7,123.6% |
| All | +76,920.8% | +1,125.5% | +75,795.2% | +33,400.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ABBV.
Daily Out/Under-Performance
Portfolio return minus ABBV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ABBV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ABBV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling